VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 168 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 3.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $85 | -63.5% | 19,760 | -42.5% | 0.00% | -66.7% |
| Q1 2023 | $233 | -74.4% | 34,379 | -72.1% | 0.00% | -72.7% |
| Q4 2022 | $910 | -99.6% | 123,125 | +386.9% | 0.01% | +266.7% |
| Q3 2022 | $250,000 | +127.3% | 25,287 | +150.9% | 0.00% | +200.0% |
| Q2 2022 | $110,000 | -90.7% | 10,079 | -90.4% | 0.00% | -88.9% |
| Q1 2022 | $1,187,000 | -19.5% | 104,944 | +11.6% | 0.01% | +12.5% |
| Q4 2021 | $1,475,000 | +20.7% | 94,025 | +31.8% | 0.01% | +33.3% |
| Q3 2021 | $1,222,000 | +280.7% | 71,320 | +233.8% | 0.01% | +200.0% |
| Q1 2021 | $321,000 | +141.4% | 21,368 | +111.4% | 0.00% | +100.0% |
| Q4 2020 | $133,000 | -95.5% | 10,107 | -96.7% | 0.00% | -94.7% |
| Q3 2020 | $2,935,000 | +1311.1% | 303,864 | +1573.9% | 0.02% | +850.0% |
| Q2 2020 | $208,000 | +73.3% | 18,153 | +56.9% | 0.00% | +100.0% |
| Q1 2020 | $120,000 | -28.1% | 11,571 | -2.3% | 0.00% | 0.0% |
| Q2 2019 | $167,000 | -64.6% | 11,849 | -53.8% | 0.00% | -75.0% |
| Q1 2019 | $472,000 | +77.4% | 25,672 | +152.4% | 0.00% | +100.0% |
| Q4 2018 | $266,000 | +94.2% | 10,172 | +41.5% | 0.00% | +100.0% |
| Q2 2018 | $137,000 | +17.1% | 7,187 | +3.3% | 0.00% | 0.0% |
| Q1 2018 | $117,000 | -25.9% | 6,956 | -21.2% | 0.00% | 0.0% |
| Q3 2017 | $158,000 | +24.4% | 8,828 | +13.5% | 0.00% | 0.0% |
| Q2 2017 | $127,000 | 0.0% | 7,781 | -14.4% | 0.00% | 0.0% |
| Q1 2017 | $127,000 | -53.0% | 9,094 | -46.2% | 0.00% | -50.0% |
| Q4 2016 | $270,000 | -78.3% | 16,918 | -84.7% | 0.00% | -71.4% |
| Q3 2015 | $1,245,000 | -2.6% | 110,342 | +9.6% | 0.01% | -12.5% |
| Q2 2015 | $1,278,000 | +38.0% | 100,708 | +1.1% | 0.01% | +33.3% |
| Q1 2015 | $926,000 | +309.7% | 99,604 | +531.9% | 0.01% | +500.0% |
| Q4 2014 | $226,000 | -2.6% | 15,762 | +10.3% | 0.00% | 0.0% |
| Q1 2014 | $232,000 | +121.0% | 14,293 | +48.8% | 0.00% | – |
| Q3 2013 | $105,000 | – | 9,607 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 1,532,000 | $27,423,000 | 3.23% |
| Stonepine Capital Management, LLC | 300,000 | $5,370,000 | 3.16% |
| Palo Alto Investors LP | 4,155,670 | $74,386,000 | 3.13% |
| GREAT POINT PARTNERS LLC | 497,531 | $8,906,000 | 1.73% |
| Avoro Capital Advisors LLC | 988,270 | $17,690,000 | 1.37% |
| UNIVERSITY OF NOTRE DAME DU LAC | 157,781 | $2,824,000 | 0.79% |
| Birchview Capital, LP | 68,000 | $1,217,000 | 0.63% |
| Cheyne Capital Management (UK) LLP | 74,000 | $1,323,000 | 0.48% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 352,604 | $6,311,000 | 0.43% |
| 361 CAPITAL LLC | 119,554 | $2,140,000 | 0.41% |